A phase II, multicenter, open-label study of obatoclax mesylate in patients with previously untreated myelodysplastic syndromes with anemia or thrombocytopenia.
about
The role of BH3-mimetic drugs in the treatment of pediatric hepatoblastomaProtein kinase A activation by the anti-cancer drugs ABT-737 and thymoquinone is caspase-3-dependent and correlates with platelet inhibition and apoptosis.Darbepoetin alfa for anemia with myelodysplastic syndrome.Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia.
P2860
A phase II, multicenter, open-label study of obatoclax mesylate in patients with previously untreated myelodysplastic syndromes with anemia or thrombocytopenia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
A phase II, multicenter, open- ...... th anemia or thrombocytopenia.
@ast
A phase II, multicenter, open- ...... th anemia or thrombocytopenia.
@en
type
label
A phase II, multicenter, open- ...... th anemia or thrombocytopenia.
@ast
A phase II, multicenter, open- ...... th anemia or thrombocytopenia.
@en
prefLabel
A phase II, multicenter, open- ...... th anemia or thrombocytopenia.
@ast
A phase II, multicenter, open- ...... th anemia or thrombocytopenia.
@en
P2093
P1476
A phase II, multicenter, open- ...... th anemia or thrombocytopenia.
@en
P2093
Mark Berger
Martha L Arellano
P304
P356
10.1016/J.CLML.2014.04.007
P407
P577
2014-06-12T00:00:00Z